Downregulation of STAT3 enhanced chemokine expression and neutrophil recruitment in biliary atresia
Biliary atresia (BA) is an immune related disorder and STAT3 is a key signalling molecule in inflammation. This study was designed to clarify the function of STAT3 in BA. STAT3 expression was examined in patients and a mouse BA model in which STAT3 levels were further altered with a specific inhibitor or activator. Neutrophil accumulation and the levels of the neutrophil chemoattractants CXCL1 and IL-8 were determined. The effects of STAT3 inhibition on IL-8 expression were examined in human biliary epithelial cell cultures. Functional changes in liver STAT3+ neutrophils in the mouse model were analysed with 10x single cells RNAseq methods. Results showed STAT3 and p-STAT3 expression was reduced in BA liver tissue compared to control samples. Administration of a STAT3 inhibitor increased jaundice and mortality and reduced body weight in BA mice. In contrast, the STAT3 activator ameliorated BA symptoms. Extensive neutrophil accumulation together with CXCL1 upregulation, both of which were suppressed by an anti-CXCL1 antibody, were observed in the STAT3 inhibitor-treated group. Recombinant IL-8 administration increased disease severity in BA mice, and the STAT3 activator had the reverse effect. Inhibiting STAT3 increased apoptosis of human biliary epithelial cells together with upregulated IL-8 expression. RNAseq analysis revealed reduced the numbers of STAT3 expressing neutrophil in BA which was accompanied by marked enhanced interferon related anti-viral activities. In conclusion, STAT3 reduction, enhanced IL-8 and CXCL1 expression and promoted the accumulation of interferon responsive neutrophils resulting in biliary epithelial cell damage in BA.